Spectrum has also signed an exclusive collaboration with Allergan (AGN), a technology-driven global health care company, for the development and commercialization of Apaziquone, an agent aimed at treating non-muscle bladder cancer.

FORBES: Why This Tiny But Profitable Biotech May Be Gobbled Up By Big Pharma

The Indian TB control program in Mumbai follows these recommendations when treating MDR-TB and adds one more agent to the five families of medicine.

WSJ: The WHO Supports India's Fight Against MDR-TB �� Letters to the Editor